SAPA TRUONG: Open Payments
NPI 1497248892 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,452 in 21 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,452
Food & beverage: $1,360Education: $92
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $261 |
| E.R. Squibb & Sons, L.L.C. | 2 | $255 |
| Janssen Biotech, Inc. | 3 | $235 |
| Syndax Pharmaceuticals, Inc. | 2 | $129 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| Agios Pharmaceuticals, Inc. | 1 | $107 |
| SpringWorks Therapeutics, Inc. | 2 | $86 |
| Incyte Corporation | 1 | $78 |
| PFIZER INC. | 2 | $50 |
| ABBVIE INC. | 1 | $49 |
Products named: RYBREVANT, REBLOZYL, BREYANZI, ZEPZELCA, WAYRILZ, SARCLISA, PYRUKYND, REVUFORJ.
Industry payments across VA — which companies pay providers there.
